<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0017">
 <label>17</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Eltzschig</surname>
    <given-names>HK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bratton</surname>
    <given-names>DL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Colgan</surname>
    <given-names>SP.</given-names>
   </name>
  </person-group>
  <article-title>Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases</article-title>. 
  <source>Nat Rev Drug Discovery</source>. 
  <year>2014 Nov</year>;
  <volume>13</volume>(
  <issue>11</issue>):
  <fpage>852</fpage>â€“
  <lpage>869</lpage>. doi: 
  <pub-id pub-id-type="doi">10.1038/nrd4422</pub-id>
  <pub-id pub-id-type="pmid">25359381</pub-id>
 </mixed-citation>
</ref>
